SCHEMBL7818322

SCHEMBL7818322

CCc1ccc2n[c]n(C)c2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAP3K14 Q99558 1/20 0.38
ACSS2 Q9NR19 1/20 0.37
SMN1; SMN2 Q16637 4/20 0.37
NPC1 O15118 3/20 0.37
RAB9A P51151 3/20 0.37
TRPA1 O75762 1/20 0.34
ALDH1A1 P00352 4/20 0.33
KDM4E B2RXH2 3/20 0.33
GAA P10253 3/20 0.33
LMNA P02545 3/20 0.33
HPGD P15428 3/20 0.33
HTT P42858 2/20 0.33
ALOX15 P16050 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TSHR P16473 1/20 0.33
CASP1 P29466 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2A6 P11509 1/20 0.33
PARP15 Q460N3 1/20 0.33
PARP10 Q53GL7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7814935 0.86 NPC1 (0.36) MAP3K14SMN1; SMN2NPC1RAB9ATRPA1
SCHEMBL2157981 0.76 CYP11B1 (0.39) ALDH1A1KDM4EKMT2AMEN1
SCHEMBL4894034 0.76 TLR8 (0.37) NPC1RAB9AALDH1A1KDM4EGAA
SCHEMBL7814303 0.75 MAPT (0.48) ACSS2SMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL5982654 0.74 PTPN1 (0.42) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL7814408 0.74 NPM1 (0.35) SMN1; SMN2NPC1RAB9AALDH1A1HTT
SCHEMBL7815237 0.74 ESR1 (0.37) ALDH1A1KDM4EHPGDHTTHSD17B10
SCHEMBL3649032 0.72 CA12 (0.48) SMN1; SMN2NPC1RAB9AALDH1A1KDM4E
SCHEMBL7811025 0.71 SCN10A (0.35) SMN1; SMN2NPC1RAB9AALDH1A1GAA
SCHEMBL7814533 0.70 GPBAR1 (0.36) SMN1; SMN2GAAHSD17B10MAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0745600-B1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO CO (JP) 2001-10-24 EP disclosed
US-5886014-A TREATMENT AND/OR PROPHYLAXIS OF A VARIETY OF DISORDERS, INCLUDING HYPERLIPEMIA, HYPERGLYCEMIA, OBESITY, IMPAIRED GLUCOSE TOLERANCE (IGT), INSULIN RESISTANCE AND DIABETIC COMPLICATIONS SANKYO COMPANY, LIMITED (JP) 1999-03-23 US disclosed
EP-0745600-A1 Benzimidazole derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-12-04 EP disclosed